Deals, Insight journal - Dealtalk, M&A

Sigma denies sweetened buyout from Aspen

Posted on 12 August 2010

Sigma Pharmaceuticals denied Australian media reports that Aspen Pharmacare Holdings had boosted its buyout offer for the company to 65 cents per share, or $689 million; Aspen's formal bid made last month was 55 cents per share.


Read the story on Sigma's bid for Aspen (link no longer available)


Print Friendly, PDF & Email

Leave a Reply